Patents by Inventor Joel Sequeira

Joel Sequeira has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of mometasone furoate for treating airway passage and lung disease
    Publication number: 20050287080
    Abstract: The administration of aerosolize particles of mometasone furoate in the form of dry powders, solutions, or aqueous suspension for treating corticosteroid-responsive diseases of the surfaces of upper and/or lower airway passages and/or lungs, e.g., allergic rhinitis and asthma is disclosed.
    Type: Application
    Filed: August 24, 2005
    Publication date: December 29, 2005
    Inventors: Joel Sequeira, Francis Cuss, Keith Nolop, Imtiaz Chaudry, Nagamani Nagabhushan, James Patrick, Mitchell Cayen
  • Stabilized antihistamine syrup
    Publication number: 20050261280
    Abstract: An antihistaminic syrup is stabilized against degradation of the active ingredient, by the addition of about 0.05 to about 5 mg/mL of an aminopolycarboxylic acid, such as a salt of ethylenediaminetetraacetic acid.
    Type: Application
    Filed: August 1, 2005
    Publication date: November 24, 2005
    Inventors: Farah Munayyer, Frank Guazzo, Elliot Stupak, Imtiaz Chaudry, Joel Sequeira
  • Pharmaceutical compositions for the treatment of asthma
    Publication number: 20050147565
    Abstract: Disclosed are aerosolized formulations for the treatment of asthma that contain mometasone furoate and formoterol fumarate and processes for preparing the same.
    Type: Application
    Filed: March 3, 2005
    Publication date: July 7, 2005
    Inventors: Joel Sequeira, Stefan Sharpe, John Hart
  • Pharmaceutical compositions
    Publication number: 20050136009
    Abstract: Disclosed are metered dose inhalers having a metering valve to deliver a dose containing an aerosol suspension formulation, said aerosol suspension formulation comprising: an effective amount of Mometasone Furoate, Formoterol or a combination thereof; a suspension medium selected from the group consisting of 1,1,1,2,3,3,3,-heptafluoropropane, 1,1,1,2-tetrafluoroethane; and a solvent that is ethanol; wherein said formulation contains less than about 500 ?g of non-volatile residue as measured by ultraviolet spectroscopy.
    Type: Application
    Filed: October 18, 2004
    Publication date: June 23, 2005
    Inventors: Julianne Berry, Jill Sherwood, Saeed Chaudhry, Joel Sequeira
  • Antifungal composition with enhanced bioavailability
    Publication number: 20030055067
    Abstract: A liquid suspension comprising an antifungally effective amount of the micronized compound represented by the chemical structural formula I: 1
    Type: Application
    Filed: April 1, 2002
    Publication date: March 20, 2003
    Applicant: SCHERING CORPORATION
    Inventors: Stefan Sharpe, Joel Sequeira, David Harris, Shashank Mahashabde